AbbVie’s elagolix meet phase III trial target
Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand for its…
Trade war fears linger even as EU mounts pressure on Washington
Though a diplomatic intervention by the Congress had earlier alleviated the threat of a full-fledged trade war, the response of…
Companies that we want to go public this year
It’s been only three months into the year, and we have already seen two popular and much-loved companies going public…
Rihanna snaps: Snapchat’s diamond-stock turns rough
With more and more celeb critics raining on Snapchat’s parade, Rihanna certainly would not be handing over her Umbrella. The…
Facebook quizzes might reveal more that what you signed up for
“What you put on Facebook, stays on Facebook. (And anyone can take it).” This has been implied umpteen times before, but…
Is it ‘game over’ for ExxonMobil?
Once the darling of the Oil & Gas industry, ExxonMobil (XOM), has now lost its sheen. Gone are those days…
Will the US stocks rise this week?
US stocks are expected to have some heavy trading and remain on the lookout this week as the Federal Reserve…
The eBay bull is capable of charging at bearish hurdles
eBay (EBAY) is one company that often gets underplayed in retail industry discussions. While it stays safe from most of…
GM’s ‘robo-taxi’ rollout is closer than you think!
A few decades ago, when it was still a concept, autonomous transportation technology looked like a whacky idea straight out…